Medications used for balacitinib, arthritis, covid, dermatitis have been shown to treat hair loss – unknown facts

Last Monday (13) was a happy day for people suffering from hair loss in the United States. This is because the country has approved the first systematic treatment for alopecia areata, an autoimmune disease that causes hair loss.

Therefore, treatment is given with baricitinib, also known as the trade name Olmiant. Hair loss treatment is safe for adult patients with severe alopecia areata. The treatment is not specific to a specific area, but to the entire body, such as the eyebrows, eyelashes, and armpits.

According to the FDA, the US health regulator, the efficacy and safety of baricitinib have already been studied in several studies. Thus, one study demonstrated that 36 weeks of treatment restored at least 80% of a patient’s scalp coverage.

In addition, another study found that 22% (out of 184) of patients receiving 2 milligrams of Olumiant and another 35% (out of 281) receiving 4 milligrams of the drug achieved adequate scalp coverage. Was shown.

However, only 5% of patients receiving placebo, an inert substance (out of a total of 189), showed the same results. “Access to safe and effective treatment options is important for a significant number of Americans affected by severe alopecia,” said Kendal Marcus, director of the FDA’s dermatology and dentistry department. ..

Hair loss

Alopecia areata is one of the factors that cause hair loss. Thus, it is estimated that more than 300,000 people in the United States suffer from this condition each year.

In the United States, it was already approved for use in 2018. However, it was intended for adult patients receiving treatment for moderate to severe active rheumatoid arthritis. Also, in the United States, Olumiant is approved for the treatment of Covid-19 in some hospitalized adults.

In Brazil, baricitinib is also enrolled in the treatment of moderate and severe active rheumatoid arthritis and moderate and severe atopic dermatitis. Earlier this year, the drug was approved as the first drug for the treatment of Covid-19 in the unified healthcare system.


Photo: Getty Images

Alopecia became a hot topic after the 2022 Oscar ceremony in the United States. That’s because one of the guests, Jada Pinkett Smith, suffered from this condition, which led to comedian Chris Rock’s ass.

There, after hearing a comment with the main character of the movie “The Edge of Honor” (1997) in which his wife and Demi Moore shaved their hair, the night nominee Will Smith stood up and went up to the stage. , Slap on Rock’s face.

When I returned to the spectators’ seats, I shouted, “Don’t say my wife’s name,” in blasphemous words, shocking not only the audience but all the attendees.

Now some people have talked about hair loss caused by alopecia, which can be caused by genetic effects, local inflammatory processes or systemic diseases.

One of the most common types of alopecia is alopecia areata, an autoimmune disease (when cells attack the body itself). It affects about 2% of the world’s population at various levels. For example, you may have small scars on your scalp or beard, circular lesions, or no hair on your entire body.

This condition is not contagious and there is no health risk in addition to hair loss itself. According to the Brazilian Dermatological Association (SBD), only 5% of cases have complete hair loss on the body as a result of alopecia.

With the approval of baricitinib as a hair loss treatment, people suffering from alopecia now have new options.

Source: G1

Leave a Comment

Your email address will not be published.